Down 26% in a Month, Is Canopy a Buy Today?

Canopy Growth Corp (TSX:WEED) is down 26% in a month. Is it time to start bottom fishing?

| More on:
A person holds a small glass jar of marijuana.

Source: Getty Images

Canopy Growth (TSX:WEED) is not doing well in 2023. Down 26% in the month of February alone, it’s really taking investors for a ride. As I’ve written in numerous past articles, cannabis companies are struggling with profitability. Additionally, they’re suffering from a dearth of catalysts that could inspire optimism and get investors to overlook their poor fundamentals.

However, with all of these losses, pot stocks are getting “cheaper,” at least in terms of the amount of dollars it costs to buy a share. It’s not entirely clear that cannabis stocks are cheapening in terms of the amount of profit you get when you buy a share. Nevertheless, Canopy Growth itself is at least a real company, doing actual sales to actual customers. This makes it better than much of what goes on in the cannabis space, so it makes sense to assess whether the stock could be a buy.

Why Canopy is down so much

Canopy Growth is going down mainly because its last few earnings releases have been poor. In the last few quarters, Canopy has lost money and had negative revenue growth. As an example, we can look at the most recent quarter, when the company earned the following:

  • $122 million in revenue, down 20%
  • A $1.8 billion operating loss, worsened by 1,000%
  • -$2 billion in net income, down from $350 million in positive net income
  • -$5.23 in earnings per share (EPS), down from $1.02 in positive EPS

It was a pretty bad showing. And previous quarters were similar: declining revenue, massive losses, huge write-downs, and other such issues. It’s become clear that the post-legalization “growth spurt” for Canadian cannabis stocks is over. In light of this, investors should look elsewhere; a lower stock price doesn’t make something a buy if its earnings are declining even faster.

Is it a buy today?

Having looked at Canopy Growth’s most recent earnings release, it’s time to answer the question, “Is the stock a buy?”

The answer would appear to be a clear “No.” I’ve followed cannabis stocks since long before legalization, and their earnings have never been very good. When these stocks rally, it’s usually because of rumours that cannabis will be legalized somewhere — for example, in the United States at the federal level. The shares tend to give up their gains after legalization doesn’t occur. Also, in Canada, legalization never did give the big cannabis companies the catalyst they needed to become profitable. They did go through a period where their revenue growth was high, but losses increased faster than revenue, and the revenue growth reversed after a few years anyway.

If you’re just reading about cannabis stocks here for the first time, you shouldn’t be discouraged. The Canadian markets are full of great companies that have produced consistent profits over the years. Examples include Fortis, CN Railway, and Alimentation Couche-Tard. Any of those stocks would be a great addition to your portfolio. As for Canopy Growth, not so much.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alimentation Couche-Tard. The Motley Fool recommends Canadian National Railway and Fortis. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »